Record Date for the Final Dividend and AGM

Financial Results and Outcome of the Board Meeting

Additional Details Required for Corporate Announcement filed under Regulation 30 of SEBI (LODR) Regulations, 2015

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DSP Trustee Pvt Ltd & Others

Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June 2026

Intimation for Closure of Trading Window

Voting results and the Scrutinizer Report of the Postal Ballot

Outcome of Postal Ballot

Annual Secretarial Compliance Report for the Financial Year Ended 31.03.2026

Reconstitution Of Committees of Board of Directors

Completion of tenure of Mr. Raja Venkataraman as an Independent Director.

Postal Ballot Notice

Notice of Postal Ballot

Financial Results - Machine Readable Format

Investor Presentation for the Quarter and year ended 31st March 2026

Intimation on rolling out of the revised Second Phase "ESOP 2" of the existing ESOP Scheme of the Company by the name of "Amrutanjan Health Care Limited - Employee Stock Option Scheme 2020".

Re-appointment of Mr. S Muralidharan as Non-Executive Independent Director w.e.f 29 June 2026.

Appointment of Mr. Ramaswami Krishnan as an Additional Director designated as Non-Executive Independent Director w.e.f 8 May 2026.

Outcome of Board Meeting

Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2026 ,inter alia, to consider and approve Audited Financial Results ....

Rephrasing of ESOP

Product Launch

Certificate Under Reg.74(5) of SEBI (DP) Regulation 2018

Closure of Trading Window for the Quarter and Year Ending 31st March 2026

Intimation of under Regulation 30 read with Clause 20 of Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Intimation of under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Record date for the second interim dividend is 7 February 2026.

Investor Presentation for the Quarter and Nine Months Ended 31st December 2025

Board Meeting Outcome for Unaudited Financial Results for the Quarter and nine months ended December 31, 2025.

Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 ,inter alia, to consider and approve the Unaudited Financial ....

Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018

Closure of Trading Window for the Quarter Ending 31st December 2025

Investor Presentation for the Quarter Ended 30th September 2025

Record date for the first interim dividend is 18 November 2025.

Unaudited Financial results for the quarter and half year ended September 30, 2025

Amrutanjan Health Care Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2025 ,inter alia, to consider and approve Un-Audited Financial ....

Disclosure under Regulation 30 of SEBI LODR 2015

Product Launch

Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations 2018

Scrutinizer Report and Voting Results

Submission of revised covering letter with the proceedings of 88th Annual General Meeting held on Tuesday, 23 September 2025.

Cessation of Mr. Govindan Raghavan (DIN 00820000) as Non-Executive Director of the Company, due to retirement by rotation.

Proceedings of 88th Annual General Meeting held on September 23, 2025.

Report for the Month of August 2025 is enclosed

Intimation regarding Special Window for Relodgement of Shares

Corrigendum to Annual Report for the Financial Year 2024-2025

Corrigendum to Annual Report for the Financial Year 2024-2025

BRSR Report for the financial year ended March 31, 2025.